Blake Borgeson is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 6.65 Million shares of RXRX, which is worth approximately $27.5 Million. The most recent transaction as insider was on Apr 20, 2021, when has been sold 7,688,356 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.65M
6.21% 3M change
5.91% 12M change
Total Value Held $27.5 Million

Blake Borgeson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 20 2021
BUY
Conversion of derivative security
-
7,688,356 Added 50.0%
7,688,356 Class A Common Stock
Apr 16 2021
BUY
Grant, award, or other acquisition
-
6,250 Added 0.09%
6,765,304 Common Stock
BB

Blake Borgeson

Director
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX